Similar articles for PMID: 26686508

Year	Number of Results
1986	1
1991	1
1992	1
1993	2
1995	4
1996	3
1997	7
1998	2
1999	3
2000	2
2001	3
2002	5
2003	2
2004	5
2005	4
2006	7
2007	7
2008	5
2009	4
2010	6
2011	11
2012	3
2013	5
2014	4
2015	3
2016	4
2017	2
2018	3
2019	1
2021	2
2022	2
2023	2
2024	0

1

The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule.

Rusmil K, Gunardi H, Fadlyana E, Soedjatmiko, Dhamayanti M, Sekartini R, Satari HI, Risan NA, Prasetio D, Tarigan R, Garheni R, Milanti M, Hadinegoro SR, Tanuwidjaja S, Bachtiar NS, Sari RM. Rusmil K, et al. BMC Pediatr. 2015 Dec 19;15:219. doi: 10.1186/s12887-015-0525-2. BMC Pediatr. 2015. PMID: 26686508 Free PMC article. Clinical Trial.

2

Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.

Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ. Punjabi NH, et al. Vaccine. 2006 Mar 10;24(11):1776-85. doi: 10.1016/j.vaccine.2005.10.023. Epub 2005 Oct 27. Vaccine. 2006. PMID: 16303216 Clinical Trial.

3

A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity.

Nolan T, Hogg G, Darcy MA, Skeljo M, Carlin J, Boslego J. Nolan T, et al. Vaccine. 2001 Feb 28;19(15-16):2127-37. doi: 10.1016/s0264-410x(00)00403-5. Vaccine. 2001. PMID: 11228385 Clinical Trial.

4

Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.

Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ Jr. Chotpitayasunondh T, et al. Southeast Asian J Trop Med Public Health. 1997 Mar;28(1):91-8. Southeast Asian J Trop Med Public Health. 1997. PMID: 9322290 Clinical Trial.

5

Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b.

Martins Rde M, Camacho LA, Marcovistz R, Noronha TG, Maia Mde L, dos Santos EM, Barbosa GG, Silva AM, Souza PC, Lemos MC, Homma A. Martins Rde M, et al. Mem Inst Oswaldo Cruz. 2008 Nov;103(7):711-8. doi: 10.1590/s0074-02762008000700014. Mem Inst Oswaldo Cruz. 2008. PMID: 19057823 Free article. Clinical Trial.

6

Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.

Lehmann D, Kakazo M, Saleu G, Taime J, Javati A, Namuigi P, Alpers MP, Wegmüller B, Zellmeyer M, Fürer E, Que JU, Herzog C. Lehmann D, et al. P N G Med J. 2001 Mar-Jun;44(1-2):6-16. P N G Med J. 2001. PMID: 12418673 Clinical Trial.

7

Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.

Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Miller MA, et al. Pediatrics. 1995 Apr;95(4):522-7. Pediatrics. 1995. PMID: 7700752 Clinical Trial.

8

Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.

Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Hla KH, et al. Pediatr Infect Dis J. 2006 Aug;25(8):706-12. doi: 10.1097/01.inf.0000223488.80814.df. Pediatr Infect Dis J. 2006. PMID: 16874170 Clinical Trial.

9

Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.

Panpitpat C, Thisyakorn U, Chotpitayasunondh T, Fürer E, Que JU, Hasler T, Cryz SJ Jr. Panpitpat C, et al. Bull World Health Organ. 2000;78(3):364-71. Bull World Health Organ. 2000. PMID: 10812736 Free PMC article.

10

DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months old.

Gunardi H, Rusmil K, Fadlyana E, Soedjatmiko, Dhamayanti M, Sekartini R, Tarigan R, Satari HI, Medise BE, Sari RM, Bachtiar NS, Kartasasmita CB, Hadinegoro SRS. Gunardi H, et al. BMC Pediatr. 2018 May 28;18(1):177. doi: 10.1186/s12887-018-1143-6. BMC Pediatr. 2018. PMID: 29804542 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year